Osaka, Japan –November 21, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of partial change applications by the Ministry of Health, Labour and Welfare (MHLW) for LEVOFOLINATE I.V. Infusion 25 mg [SAWAI] and 100 mg [SAWAI]*.
This approval expands the indication of LEVOFOLINATE I.V. Infusion 25 mg [SAWAI] and 100 mg [SAWAI] to include the ... Read More
QUDEXY® XR’S ACCESS PATHWAYS® PROGRAM PLATINUM PASS™ FEATURED AT BOOTH #415
Maple Grove, MN – October 25, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the American Academy of Neurology (AAN) ... Read More
Clobazam Tablets, CIV, 10 and 20 mg Clobazam Oral Suspension, CIV, 2.5 mg/mL Upsher-Smith Laboratories, LLC
Maple Grove, MN – October 23, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Clobazam Tablets, CIV, 10 ... Read More
NCPA AWARD SPONSORED BY UPSHER-SMITH FOR TENTH CONSECUTIVE YEAR
Maple Grove, MN – October 11, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) is pleased to announce that James “Jim” Spoon DPh, an independent pharmacist with deep roots ... Read More
Exemestane Tablets, 25 mg Upsher-Smith Laboratories, LLC
Maple Grove, MN – October 11, 2017 – Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of Exemestane Tablets, 25 mg. The company recently received U.S. Food and Drug Administration (FDA) ... Read More
Osaka, Japan –September 21, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approvals from the Ministry of Health, Labour and Welfare (MHLW) for public knowledge-based applications1 for the ... Read More
Osaka, Japan –September 5, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today received approval of partial change applications by the Ministry of Health, Labour and Welfare (MHLW) for ARIPIPRAZOLE Tablets 3 mg ... Read More
Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP 2.5 mg/0.025 mg Upsher Smith Laboratories, LLC
Maple Grove, MN – August 31, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the
launch of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, ... Read More
Osaka, Japan –August 15, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approvals by the Ministry of Health, Labour and Welfare for six compounds with 13 strengths of generic drugs. Among the six compounds, four compounds, Mirtazapine, Atomoxetine Hydrochloride, Tramadol Hydrochloride / Acetaminophen and Capecitabine, are approved for the first ... Read More
